Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eyenovia Inc.
Age
40–55
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Poor near vision impacting daily living that requires near correction
Best-corrected distance visual acuity (BCDVA) of 0.0 logMar or better
Manifest refraction spherical equivalent ≥ -2.00 Diopters (D) and ≤ +2.00 D
Monocular DCNVA between 0.4 and 0.7 logMAR, inclusive
In need of near addition power \< +2.00 D to achieve BCNVA of 0.0 logMAR
You may not be if
Diagnosis of glaucoma or ocular hypertension
Narrow iridocorneal angles
History of intraocular surgery, refractive surgery, laser treatment, or iris surgery
Clinically significant abnormality of cornea, lens, retina, ciliary body, or iris
Presence/history of a severe/serious ocular condition or any other unstable medical condition
Presence or history of manifest strabismus, amblyopia, or nystagmus
Current active eye disease for which topical or systemic ophthalmic medication is necessary, except for dry eye syndrome managed using artificial tears
Clinically significant external ocular inflammation within 30 days of Screening Visit
Current use or history of rigid gas permeable (RGP) contact lens use within 30 days of Screening Visit
Known pilocarpine allergy or contraindication to use of pilocarpine
Presence or history of congenital heart anomaly, valve disease, or other cardiac disease
Disabling arthritis or limited motor coordination that would limit the subject's ability to self-administer study solution using the Optejet
Clareo Health | Safety & Efficacy of Pilocarpine Ophthalmic Spray for Temporary Improvement of Near Vision in Presbyopic Adults
